Who owns Oramed Pharm?
- Ticker: ORMP
- CUSIP Number: 68403P203
Tip: Access positions for across all investors
Analyze quarterly positions in Oramed Pharm with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Oramed Pharm stock
Who bought or sold Oramed Pharm this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BML Capital Management | 845k | $2.5M | -33% | Mar 2024 |
|
Two Sigma Advisers | 284k | $655k | 71% | Dec 2023 |
|
Bank of America Corporation | 271k | $627k | 1222% | Dec 2023 |
|
Two Sigma Investments | 157k | $363k | 399% | Dec 2023 |
|
Squarepoint Ops | 117k | $271k | 122% | Dec 2023 |
|
Jane Street | 96k | $221k | 775% | Dec 2023 |
|
D. E. Shaw & Co | 59k | $137k | 100% | Dec 2023 |
|
Citadel Advisors | 44k | $102k | 109% | Dec 2023 |
|
Jpmorgan Chase & Co | 29k | $66k | -37% | Dec 2023 |
|
Pnc Financial Services | 26k | $61k | -4% | Dec 2023 |
|
Assenagon Asset Management | 19k | $55k | 100% | Mar 2024 |
|
Algert Coldiron Investors | 15k | $34k | 0% | Dec 2023 |
|
Barclays | 13k | $30k | -28% | Dec 2023 |
|
N.E.W. Advisory Services | 13k | $38k | 0% | Mar 2024 |
|
Altshuler Shaham | 13k | $30k | 0% | Dec 2023 |
|
Wealth Enhancement Advisory Services | 11k | $33k | -4% | Mar 2024 |
|
Close Asset Management | 11k | $26k | 0% | Dec 2023 |
|
Hrt Financial | 11k | $25k | 100% | Dec 2023 |
|
Glass Jacobson Investment Advisors | 11k | $31k | 0% | Mar 2024 |
|
Royal Bank of Canada | 9.2k | $21k | 75% | Dec 2023 |
|
AJOVista | 8.4k | $19k | 100% | Dec 2023 |
|
Advisor Group Holdings | 8.4k | $19k | -57% | Dec 2023 |
|
UBS Group | 5.1k | $12k | -18% | Dec 2023 |
|
Huntington National Bank | 5.0k | $12k | 0% | Dec 2023 |
|
Wells Fargo & Company | 4.5k | $10k | 0% | Dec 2023 |
|
LM Advisors | 2.5k | $5.8k | 100% | Dec 2023 |
|
McIlrath & Eck | 2.0k | $4.6k | 0% | Dec 2023 |
|
Rhumbline Advisers | 1.8k | $4.2k | 0% | Dec 2023 |
|
IFP Advisors | 1.5k | $3.5k | -14% | Dec 2023 |
|
City Holding | 1.1k | $3.1k | 0% | Mar 2024 |
|
Proequities | 1.0k | $2.3M | 0% | Dec 2023 |
|
Newbridge Financial Services Group | 657.00 | $1.9k | 0% | Mar 2024 |
|
Federated Investors | 369.00 | $851.984100 | 202% | Dec 2023 |
|
Tyler-Stone Wealth Management | 300.00 | $693.000000 | 0% | Dec 2023 |
|
Beacon Capital Management | 219.00 | $572.006100 | 0% | Dec 2023 |
|
Global Retirement Partners | 100.00 | $292.000000 | 0% | Mar 2024 |
|
Brown Brothers Harriman & Co. | 8.00 | $18.000000 | 0% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 2.00 | $5.000000 | -85% | Dec 2023 |
|
Who sold out of Oramed Pharm?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Goldman Sachs Group | Sep 2023 | 154k | $401k |
GSA Capital Partners | Sep 2023 | 89k | $232k |
Citigroup | Sep 2023 | 42k | $108k |
Dimensional Fund Advisors | Sep 2023 | 27k | $71k |
Virtu Financial | Sep 2023 | 17k | $45k |
Bourgeon Capital Management | Dec 2023 | 5.6k | $13k |
TD Waterhouse Canada | Sep 2023 | 1.0k | $2.6k |